Results 181 to 190 of about 387,427 (329)
Compact Multichannel Plasmonic Device for Rapid and Versatile Inflammatory Biomarker Analysis
A multichannel plasmonic biosensor has been developed for the simultaneous detection of up to four inflammatory biomarkers relevant to sepsis diagnostics. Its performance has been optimized, and analytical validation has been conducted for the detection in diluted serum, highlighting its potential for clinical applications.
Juliana Fátima Giarola+3 more
wiley +1 more source
Immunopathogenesis of inflammatory bowel diseases
The aim of review. To present analysis of data on immunopathogenesis of inflammatory bowel diseases.Key points. At genetically sensitive animals inflammatory bowel diseases (IBD) develop at various effects on innate and adaptive systems of immune defense
Ye. A. Konovich+2 more
doaj
Emerging microphysiological systems reproduce the spatial, biochemical, and cellular complexity of the tumor microenvironment, surpassing 2D cultures and murine models. By integrating patient‐derived tumors, perfusable vasculature, and immune trafficking, these organ‐on‐chip platforms reveal mechanisms of immune evasion, predict therapeutic responses ...
Fabiana Moresi+5 more
wiley +1 more source
Summary: The hypertrophic mesenteric adipose tissue (htMAT) of Crohn disease (CD) participates in inflammation through the expression of adipokines, but the exact mechanism of this action in the intestine is unknown.
Xiaofeng Zhang+12 more
doaj
The multifaceted role of sirtuins in inflammatory bowel diseases. [PDF]
Samant SA+3 more
europepmc +1 more source
Escherichia coli antibodies in patients with inflammatory bowel disease.
S. Tabaqchali+2 more
openalex +1 more source
Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. [PDF]
A Zifroni+3 more
openalex +1 more source
Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar+7 more
wiley +1 more source
Angiogenic Factors and Inflammatory Bowel Diseases. [PDF]
Li Z+5 more
europepmc +1 more source
Evolution of Ocular Organ‐On‐Chip Systems for Disease Modelling and Drug Testing: Where are We Now?
The rise in ophthalmic diseases due to aging, screen use, and environmental factors has driven demand for better ocular models. Traditional systems fall short, encouraging the development of organ‐on‐chip devices. These microfluidic platforms replicate eye tissue architecture, enable drug screening, and simulate ocular diseases.
Sara Trujillo
wiley +1 more source